UBS Reiterates Buy Rating on 89bio Inc. (ETNB) Following Agreement to be Acquired by Roche
Tweet Send to a Friend
UBS analyst Eliana Merle reiterated a Buy rating and $38.00 price target on 89bio Inc. (NASDAQ: ETNB).The analyst commented, "Announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
